Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
About
Company
Leadership
Careers
Platform
Platform Overview
DELIVER Platform
Cargo Platform
Pipeline
Development Programs
Duchenne Muscular Dystrophy (DMD)
Facioscapulohumeral Dystrophy (FSHD)
Publications
Newsroom
Careers
Contact
linkedin
Newsroom
Press Releases, Media Coverage and Publications
Press Releases
Media Coverage
Media Contact
News Alerts
Press Releases
Kate Therapeutics Unveils Platform and Pipeline Progress at American Society of Gene & Cell Therapy 2024 Annual Meeting
May 9, 2024
Capsida Biotherapeutics Enters Strategic Collaboration With Kate Therapeutics to Manufacture KateTx’s Next-Generation Gene Therapies
October 3, 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
June 8, 2023
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
June 8, 2023
Media Coverage
Kate Raises The Bar for DMD Gene Therapy [Biocentury]
May 9, 2024
New Drugs May Help Rebuild Momentum against Cardiovascular Disease [GEN]
October 10, 2023
The 20 Under 40 in Biopharma [Endpoint News]
April 19, 2022
A Boost for Muscle with Gene Therapy [NEJM]
March 24, 2022
Determined Yet Patient, He Looks for a Cure [New York Times]
November 4, 2021
Engineering a Better Way to Deliver Therapeutic Genes to Muscles [NIH Director’s Blog]
September 21, 2021
Media Contact
Kathy Vincent
Greig Communications, Inc.
kathy@greigcommunications.com
Subscribe to Receive News Alerts
Fill out my
online form
.
Close Menu
About
Company
Leadership
Careers
Platform
Platform Overview
DELIVER Platform
Cargo Platform
Pipeline
Development Programs
Duchenne Muscular Dystrophy (DMD)
Facioscapulohumeral Dystrophy (FSHD)
Publications
Newsroom
Careers
Contact
linkedin
